BNP Paribas’s Bristol-Myers Squibb BMY Stock Holding History

BNP Paribas’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.2M	Buy	118,501 +39,456	+50%	+$2.3M	0.23%	77
2025 Q4	$4.26M	Buy	79,045 +42,960	+119%	+$2.07M	0.12%	102
2025 Q3	$1.63M	Sell	36,085 -27,033	-43%	-$1.26M	0.05%	136
2025 Q2	$2.92M	Buy	63,118 +22,262	+54%	+$1.09M	0.09%	114
2025 Q1	$2.65M	Buy	40,856 +26,494	+184%	+$1.54M	0.11%	109
2024 Q4	$1.93M	Sell	14,362 -25,101	-64%	-$1.4M	0.01%	120
2024 Q3	$2.03M	Buy	39,463 +28,453	+258%	+$1.33M	0.08%	103
2024 Q2	$457K	Sell	11,010 -16,291	-60%	-$729K	0.02%	193
2024 Q1	$1.48M	Buy	+27,301	New	+$1.39M	0.07%	123

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas's BMY Position: Q1 2026 in Review

BNP Paribas increased its Bristol-Myers Squibb (BMY) stake by 50% in Q1 2026, buying an estimated $2.3M and bringing the position to 118,501 shares worth $7.2M. The position accounts for 0.23% of the portfolio, ranked #77.

BNP Paribas first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

BNP Paribas held 118,501 shares of Bristol-Myers Squibb worth $7.2M as of Q1 2026.
BNP Paribas bought 39,456 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.3M.
Bristol-Myers Squibb made up 0.23% of BNP Paribas's portfolio in Q1 2026, its #77 holding.
BNP Paribas first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.